A股异动丨青青稞酒(002646.SZ)跌近6% 股东纷纷减持
格隆汇11月25日丨青青稞酒(002646.SZ)低开低走,现跌近6%,报17.55元,总市值79亿元。本周一青青稞酒(002646.SZ)股价一度刷新逾三年来新高。青青稞酒昨日公布,近日,公司收到控股股东华实投资《关于股份减持计划进展的告知函》,华实投资自2020年8月25日至2020年11月23日通过集中竞价交易方式累计减持公司股份481.88万股,占公司总股本的1.0708%。此外,截至2020年11月19日,控股股东减持时间已过半,华实投资自2020年8月25日至2020年11月19日通过集中竞价交易方式累计减持公司股份449.58万股,占公司总股本的0.9991%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.